Nature of Reviews

Every board on this site puts sellers in an order, and an order is worth nothing if you cannot see how it was produced. This page describes exactly what goes into a sermorelin verdict, what is structurally incapable of influencing it, and how to read the partner labels. It sits alongside our disclosures and editorial policy.

1. What we score

Three inputs, the same three our published rubric weights, applied identically to every provider, from the cheapest monthly plan to the largest annual prepay:

• Evidence — what human trials show for that specific format. The only placebo-controlled adult trial behind sermorelin used a nightly injection; no format inherits that evidence just because it shares the molecule’s name.
• Price transparency — whether the cost appears before an intake form, and whether a headline rate is a monthly price or a year billed at once. Those are not the same number and we do not let them be compared as if they were.
• Value — what a month actually costs in the format you’d choose, since injection, oral and troche are frequently priced differently by the same seller.

The standard behind those inputs — primary sources, citations verified live, effect sizes rather than adjectives — is in our methodology.

2. The score cannot see who pays

This is a property of the code, not a promise about our character. The function that produces a provider’s score never reads its commercial status; that field is not among its inputs, and a test asserts it. No score on this site was typed in by hand.

That is no longer true of the whole site, and we would rather say so plainly than let an old sentence quietly go stale: 9 sellers we cover pay us today. They are labeled Partner wherever they appear and sort ahead of non-partners on their board. What has not changed is the score beside them: still computed by a function that cannot read commercial status, on every provider alike.

The place to check us is the disclosure page, which lists what we earn from and what we have declined, and the rubric itself, which is published rather than described.

A verdict that only ever flattered the people paying us would not produce those three pages.

3. How partners appear

Sermorelin Picks is reader-supported. Some providers we review are commercial partners, reached through the Katalys network: if you start care through our link we may earn a commission, at no extra cost to you. Two consequences, both worth stating plainly:

• Commercial links are labeled where they appear, not only in a policy page you would have to go looking for.
• A partnership can affect the order things are listed in. It cannot affect the verdict, the score, or a safety statement. When a partner is shown first, that is placement. It is not a claim that they are better, and the review immediately below will tell you if they are not.

Our affiliate disclosure is computed from the links actually present on the page you are reading, rather than asserted site-wide. A page that earns nothing does not claim to.

4. Providers we earn nothing from

Most sellers we cover have no commercial relationship with us. Their links are not affiliate links, and we earn nothing when you use them. Not being a partner neither helps nor hurts the score or what we write; it means only that the seller is listed after the partners.

5. What we do not cover, and how fast it goes stale

We do not review every sermorelin seller in existence. Coverage follows what people are actually deciding between and where evidence exists to decide on. In a compounded market, prices, state availability and regulatory standing move without notice, and every price here was read off the seller’s own page on a stated date — not from a program description, which routinely disagrees with it. Check the current figure before you buy, and treat all of this as research rather than medical advice. If something here is out of date, tell us — if you are right, we fix the page.